Loading…
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Schedule | Awardee / L1 Bidder | Status | Bids | Value |
|---|---|---|---|---|---|
| 1 | Schedule 1 | Keps Pharma | Awarded | 1 | ₹1.6 L |
| 2 | Schedule 2 | Keps Pharma | Awarded | 1 | ₹2.0 L |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
3 Jul 2025, 9:00 amClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
MDI Glycopyrrolate IP 9mcg
Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg
MDI Glycopyrrolate IP 9mcg & Formoterol Fumerate 4.8mcg
7777730
GEM/2025/B/6174432
Two Packet Bid
MDI Glycopyrrolate IP 9mcg, Formoterol Fumerate 4.8mcg &
30 days
Maharashtra; Mumbai
Item wise evaluation
PRODUCT_CUSTOM
6 documents required · 6 mandatory
2 yrs
₹2 L
₹6 L
20%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| MDI Glycopyrrolate IP 9mcg | - | - | - |
| Formoterol Fumerate 4.8mcg & Budesonide IP 160 mcg | - | - | - |
| MDI Glycopyrrolate IP 9mcg & Formoterol Fumerate 4.8mcg | - | - | - |
Exempted
3 Jul 2025
11 Jun 2025
3 Jul 2025
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7777730.pdf
GEM_BID
bbqr_medicine_2025-04-26-13-23-50_3c37e3aab6f8455779a1ed802e801a85.pdf
SPECIFICATION
bbqr_medicine_2025-04-26-13-25-44_f05ea86a9d1ba1689b0c077f7cec926b.pdf
SPECIFICATION
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .